JP2025521083A5 - - Google Patents
Info
- Publication number
- JP2025521083A5 JP2025521083A5 JP2024566233A JP2024566233A JP2025521083A5 JP 2025521083 A5 JP2025521083 A5 JP 2025521083A5 JP 2024566233 A JP2024566233 A JP 2024566233A JP 2024566233 A JP2024566233 A JP 2024566233A JP 2025521083 A5 JP2025521083 A5 JP 2025521083A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrogen
- compound according
- alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263340191P | 2022-05-10 | 2022-05-10 | |
| US63/340,191 | 2022-05-10 | ||
| US202263383190P | 2022-11-10 | 2022-11-10 | |
| US63/383,190 | 2022-11-10 | ||
| PCT/US2023/066601 WO2023220541A1 (en) | 2022-05-10 | 2023-05-04 | Tetrahydropyrido[3,4-d]pyrimidines compounds as hpk1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025521083A JP2025521083A (ja) | 2025-07-08 |
| JP2025521083A5 true JP2025521083A5 (cg-RX-API-DMAC7.html) | 2026-05-14 |
Family
ID=86688794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024566233A Pending JP2025521083A (ja) | 2022-05-10 | 2023-05-04 | HPK1阻害剤としてのテトラヒドロピリド[3,4-d]ピリミジン化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240025922A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4522618A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025521083A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119546610A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023267747A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3250387A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL316818A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202400612A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023220541A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025210407A1 (en) * | 2024-04-01 | 2025-10-09 | Merck Patent Gmbh | (7-{1h,2h,3h-pyrido [2,3-b][1,4]oxazin-7-yl}-5h,6h,7h,8h-pyrido[3,4-d]pyrimidin-2-yl)amine derivatives as bifunctional degraders of hpk1 for the treatment of cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019010302A (es) * | 2017-03-30 | 2019-11-21 | Hoffmann La Roche | Isoquinolinas como inhibidores de hpk1. |
-
2023
- 2023-04-21 TW TW112114997A patent/TW202400612A/zh unknown
- 2023-05-04 AU AU2023267747A patent/AU2023267747A1/en active Pending
- 2023-05-04 CN CN202380052662.0A patent/CN119546610A/zh active Pending
- 2023-05-04 IL IL316818A patent/IL316818A/en unknown
- 2023-05-04 WO PCT/US2023/066601 patent/WO2023220541A1/en not_active Ceased
- 2023-05-04 EP EP23728556.4A patent/EP4522618A1/en active Pending
- 2023-05-04 JP JP2024566233A patent/JP2025521083A/ja active Pending
- 2023-05-04 CA CA3250387A patent/CA3250387A1/en active Pending
- 2023-05-08 US US18/313,652 patent/US20240025922A1/en active Pending